Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
Clinical trial NCT04711824 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04711824
- Sponsor
- Colette Shen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2026-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.